Childhood Apraxia of Speech
11
3
5
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
Motor-based Intervention for Childhood Apraxia of Speech: DTTC-Connect
Role of Omega-DEK in Childhood Apraxia of Speech
A Randomized Control Trial of Motor-based Intervention for CAS
The Effects of Caregiver Training on DTTC Treatment Outcomes in CAS
Methylphenidate in Childhood Apraxia of Speech
Efficacy of Ultrasound Biofeedback in Brazilian Childhood Apraxia of Speech
Dose Frequency RCT on DTTC in Children With CAS
ASSIST: Treatment for Childhood Apraxia of Speech
Treatment of Cantonese Speakers With Childhood Apraxia of Speech
Childhood Apraxia of Speech: Experience Dependent Changes Induced by Treatment
Treating Childhood Apraxia of Speech